Message from the Director of the Department
The Ophthalmology Department is actively engaged in the treatment of severe diseases including proliferative diabetic retinopathy and glaucoma (both major diseases that cause acquired blindness), training of diplomates of ophthalmology, and research on the development of new therapy in addition to education for students as the primary objective of university. The department also has introduced not only state-of-the-art test apparatus such as a high-resolution optical coherence tomography but also the latest surgical devices, offering medicine equivalent to the world’s leading-edge technology.
Ophthalmology DepartmentFumio Shiraga
Scope of Target Diseases
1. Maculopathy/vitreoretinal disease: Intravitreal injection of angiogenesis inhibitor is performed for age-related macular degeneration. Treatment suitable for a patient’s condition is administered for retinal detachment, diabetic retinopathy, macular edema, macular hole, and preretinal macular fibrosis.
2. Glaucoma: Drug therapy, laser therapy, and surgery are used depending on a patient’s condition. We also strive for more accurate diagnosis and better therapeutic outcomes using the latest test methods and surgical procedures.
3. Strabismus/amblyopia: Optimal treatment is performed for each case.
4. Corneal/anterior eye disease: Corneal transplantation using the latest technology is performed for corneal diseases such as corneal opacity and bullous keratopathy.
5. Ocular inflammation (uveitis): Treatment is performed with emphasis on drug therapy such as molecular targeted therapy. Surgery is performed depending on the case.
6. Cataracts: We also accept challenging cases.
7. Low vision: Patients who have low vision irrespective of the primary disease can try and select optical aids such as magnifying glasses, text magnifiers, and light-shield glasses in practice.
Features and Description of Medical Care
The Ophthalmology Department always endeavors to improve patient vision quality, incorporating the latest therapeutic technology. Major diseases in the scope of treatment at our department include the following: maculopathy such as age-related macular degeneration; vitreoretinal disease such as retinal detachment, diabetic retinopathy, age-related macular degeneration; glaucoma, strabismus/amblyopia, corneal and anterior eye diseases, ocular inflammatory diseases, and other general ocular diseases. Recent trends can be characterized in the increasing tendency of diseases specific to adults, and to elderly people in particular, in the current situation of our aging society. Ninety percent of patients admitted to the Ophthalmology Department that they need surgery. The department has always had a greater number of patients among the number of cases of surgery in our operating room in the last few years. The treatment policy for each inpatient who needs surgery is reviewed, exchanging opinions in operation conferences performed every week and in consultation by a professor/ associate professor depending on each patient’s situation. For outpatients, medical care based on expertise is provided by a professor, associate professor, assistant professor, and specialized outpatient physician.